FCGR2A and dengue disease: To achieve these goals, several future research directions are critical for advancing dengue vaccine efficacy and safety: (1) Phase IV studies of vaccine‐induced ADE are important: Conducting Phase IV studies is essential to evaluate ADE, focusing on FcγR‐mediated suppression and NS1‐induced endothelial damage to refine vaccine strategies.